「Vancomycin」の共起表現(1語左で並び替え) - Weblio英語共起表現検索


小窓モード

プレミアム

ログイン
設定

設定

Weblio 辞書 > 英和辞典・和英辞典 > Vancomycinの意味・解説 > Vancomycinに関連した共起表現

「Vancomycin」の共起表現一覧(1語左で並び替え)

該当件数 : 20



, ranitidine, triamterene, trimethoprim, and vancomycin) and certain drugs tend to produce hyperglyc
e with the current “last defence” antibiotic vancomycin.
ical drugs, including the natural antibiotic vancomycin, the antihistamine loratadine (Claritin), th
coming resistant against such antibiotics as vancomycin.
It belongs to the same class as vancomycin, the most widely-used and one of the few tre
e natural glycopeptides currently available, vancomycin and teicoplanin.
The original indication for vancomycin was for the treatment of penicillin-resistan
Several derivatives of vancomycin are currently being developed, including ori
use of cloxacillin may permit reduced use of vancomycin.
istically non-inferior to the combination of vancomycin and ceftazidime for the treatment of skin an
This binding of vancomycin to the D-Ala-D-Ala prevents the incorporatio
residue has been replaced by a D-lactate, so vancomycin cannot bind.
Possessing longer half-lives than vancomycin, these newer candidates may demonstrate impr
etrating into leucocytes and phagocytes than vancomycin.
It is more lipophillic than vancomycin, as it has more fatty acid chains.
to be 50 to 100 times more lipophillic than vancomycin.
It can be two to four times more active than vancomycin, but it does depend upon the organism.
strates an inherent, low level resistance to vancomycin.
lanin has an increased half life compared to vancomycin, as well as having better tissue penetration
n-inferior efficacy against MRSA compared to vancomycin and aztreonam Recently, ceftaroline has comp
                                                                                                    


こんにちは ゲスト さん

ログイン

Weblio会員(無料)になると

会員登録のメリット検索履歴を保存できる!

会員登録のメリット語彙力診断の実施回数増加!

無料会員に登録する
英→日 日→英
こんにちは ゲスト さん

ログイン

Weblio会員(無料)になると

会員登録のメリット検索履歴を保存できる!

会員登録のメリット語彙力診断の実施回数増加!

無料会員に登録する

©2024 GRAS Group, Inc.RSS